On The Pen With Dave Knapp

By: Dave Knapp Man On The Mounjaro
  • Summary

  • Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!

    © 2024 On The Pen With Dave Knapp
    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Dr Spencer Nadolsky: Docs Who Lift Pod | OTP Eps 90
    Nov 15 2024

    Send us a text

    Dr Spencer Nadolski of the “Docs Who Life” podcast joins Dave to recap obesity week, and to deep dive into Dave’s ongoing struggle with obesity and type 2 diabetes.

    Onthepen.TV

    Support the show

    DNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
    USE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!

    MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
    Venmo: OnThePen
    Ca$h App: ManOnMounjaro

    BECOME A MEMBER:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    👉 My Amazon Affiliate Store:
    https://www.amazon.com/shop/manonthemounjaroonthepen

    MORE COMMUNITY!
    📺 Watch Our Weekly Live Show: onthepen.tv
    🆕 Discord: https://discord.gg/u4Ea8qqP

    🤝 Visit Our Sponsor!
    GLP-1 Ro Body Plan: https://www.ro.co/otp
    Report The Shortage: https://www.ro.co/supply-tracker
    Does your insurance cover GLPs? https://www.ro.com/checker

    📲 Contact Me: dave@onthepen.com

    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepe...

    Show More Show Less
    1 hr and 36 mins
  • Novo Nordisk's War on Compound Semaglutide, Maritide Has Some Negative News
    Nov 12 2024

    Send us a text

    In this episode of On The Pen: The Weekly Dose, host Dave Knapp dives into the latest updates in obesity medicine, with insightful takes on current treatment breakthroughs, new medication approvals, and tips on navigating healthcare options. This week’s deep dive also touches on emerging trends in GLP-1 therapy and how recent shifts may impact accessibility for patients. Whether you’re just starting your journey or a long-time follower of GLP-1 news, this episode brings you the essentials. ​

    Maritide Bone Density Loss:
    https://www.statnews.com/2024/11/12/amgen-maritide-obesity-drug-candidate-data/

    Catalent Novo Merger:
    https://www.biospace.com/deals/lilly-vs-novo-the-he-said-she-said-row-about-catalents-glp-1-work

    Novo War On Compounds:
    https://www.onthepen.com/post/shocking-truth-about-semaglutide-what-novo-nordisk-doesn-t-want-you-to-know

    Drug Shortage Policy Reform Request (VOTE!):
    https://forum.policiesforpeople.com/t/compound-tirzepatide-and-semaglutide-transparency-in-fda-drug-shortage-process-503b-protection/7821

    Onthepen.TV

    Support the show

    DNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
    USE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!

    MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
    Venmo: OnThePen
    Ca$h App: ManOnMounjaro

    BECOME A MEMBER:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    👉 My Amazon Affiliate Store:
    https://www.amazon.com/shop/manonthemounjaroonthepen

    MORE COMMUNITY!
    📺 Watch Our Weekly Live Show: onthepen.tv
    🆕 Discord: https://discord.gg/u4Ea8qqP

    🤝 Visit Our Sponsor!
    GLP-1 Ro Body Plan: https://www.ro.co/otp
    Report The Shortage: https://www.ro.co/supply-tracker
    Does your insurance cover GLPs? https://www.ro.com/checker

    📲 Contact Me: dave@onthepen.com

    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepe...

    Show More Show Less
    26 mins
  • Viking Therapeutics and AstraZeneca Steal The Show at Obesity Week!
    Nov 5 2024

    Send us a text

    Semaglutide News: https://www.onthepen.com/post/select-trial-update-semaglutide-s-cardiovascular-benefits-and-psychiatric-safety-profile-highlighte

    Viking Therapeutics News:
    https://www.onthepen.com/post/vk2735-vikingtide

    AstraZeneca News:
    https://www.onthepen.com/post/astrazeneca-s-azd5004-a-power-move-in-obesity-medicine

    Onthepen.TV

    Support the show

    DNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
    USE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!

    MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:
    Venmo: OnThePen
    Ca$h App: ManOnMounjaro

    BECOME A MEMBER:
    https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    👉 My Amazon Affiliate Store:
    https://www.amazon.com/shop/manonthemounjaroonthepen

    MORE COMMUNITY!
    📺 Watch Our Weekly Live Show: onthepen.tv
    🆕 Discord: https://discord.gg/u4Ea8qqP

    🤝 Visit Our Sponsor!
    GLP-1 Ro Body Plan: https://www.ro.co/otp
    Report The Shortage: https://www.ro.co/supply-tracker
    Does your insurance cover GLPs? https://www.ro.com/checker

    📲 Contact Me: dave@onthepen.com

    Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit onthepe...

    Show More Show Less
    29 mins

What listeners say about On The Pen With Dave Knapp

Average customer ratings
Overall
  • 5 out of 5 stars
  • 5 Stars
    1
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0
Performance
  • 5 out of 5 stars
  • 5 Stars
    1
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0
Story
  • 5 out of 5 stars
  • 5 Stars
    1
  • 4 Stars
    0
  • 3 Stars
    0
  • 2 Stars
    0
  • 1 Stars
    0

Reviews - Please select the tabs below to change the source of reviews.

Sort by:
Filter by:
  • Overall
    5 out of 5 stars
  • Performance
    5 out of 5 stars
  • Story
    5 out of 5 stars

Extremely Informative

As a current U.K. based Mounjaro user for PCOS concerns, I find these podcasts highly informative - guests highly knowledgeable and the approach from the podcasters clear. I have become increasingly more confident regarding side effects, studies, medical potential of glp1 medications and ‘seen’ by the podcasters with their approach regarding to discussions on ‘food noise’ since listening. Excellently done. 10/10 would recommend.

Something went wrong. Please try again in a few minutes.

You voted on this review!

You reported this review!